Nacher V, Merino J F, Raurell M, Soler J, Montanya E
Endocrine Unit, Ciutat Sanitària i Universitària de Bellvitge, Barcelona, Spain.
Diabetes. 1998 Feb;47(2):192-6. doi: 10.2337/diab.47.2.192.
We studied the effects of chronic hyperglycemia on beta-cell replication and mass in transplanted (Tx) islets. Five groups of streptozocin-induced diabetic C57Bl/6 mice were transplanted with 100 (Tx-100) syngeneic islets, an insufficient beta-cell mass to restore normoglycemia. Groups 1 and 2 remained hyperglycemic throughout the study; after 30 days of hyperglycemia, a second transplantation of 250 islets (Tx-250) restored normoglycemia in groups 3, 4, and 5. Tx-250 was harvested on day 60 in all three groups, and transient mild hyperglycemia developed (10-12 days); thereafter, Tx-100 maintained blood glucose values in the normal range. Tx-100 was harvested 14 (group 1), 60 (groups 2 and 3), 74 (group 4), and 90 (group 5) days after transplantation. Hyperglycemia increased beta-cell replication after 14 days (group 1: 1.26 +/- 0.18%, P < 0.05) but not after 60 days (group 2: 0.59 +/- 0.13%) compared with islets exposed to normoglycemia (group 3: 0.51 +/- 0.07%) (analysis of variance [ANOVA], P < 0.0002). beta-cell replication in group 4 increased after Tx-250 harvesting (0.94 +/- 0.16%, P < 0.05). The initially Tx beta-cell mass (0.21 +/- 0.014 mg) was progressively reduced in hyperglycemic groups (group 1: 0.13 +/- 0.020 mg; group 2: 0.048 +/- 0.012 mg; P < 0.05) (ANOVA, P = 0.0001). Restoration of normoglycemia after Tx-250 did not modify beta-cell mass in Tx-100 grafts (group 3: 0.076 +/- 0.008 mg). However, after Tx-250 harvesting, beta-cell mass increased progressively (group 4: 0.11 +/- 0.018 mg; group 5: 0.14 +/- 0.026 mg, P < 0.05), although it was still reduced compared with the initially Tx beta-cell mass (P < 0.05). In summary, Tx islets exposed to severe chronic hyperglycemia showed a limited beta-cell replication and a progressive reduction in beta-cell mass. With normoglycemia, the Tx beta-cells recovered the replicative response to glucose and partially restored the initially Tx beta-cell mass, indicating that normoglycemia, even after long-term hyperglycemia, has a beneficial effect in islet transplantation.
我们研究了慢性高血糖对移植胰岛中β细胞复制及数量的影响。将五组链脲佐菌素诱导的糖尿病C57Bl/6小鼠移植100个同基因胰岛(Tx - 100),该β细胞数量不足以恢复正常血糖水平。第1组和第2组在整个研究过程中一直处于高血糖状态;高血糖30天后,第3、4、5组再次移植250个胰岛(Tx - 250)后恢复正常血糖水平。所有三组均在第60天采集Tx - 250胰岛,之后出现短暂轻度高血糖(10 - 12天);此后,Tx - 100维持血糖值在正常范围内。移植后14天(第1组)、60天(第2组和第3组)、74天(第4组)和90天(第5组)采集Tx - 100胰岛。与处于正常血糖状态的胰岛(第3组:0.51±0.07%)相比,高血糖14天后β细胞复制增加(第1组:1.26±0.18%,P < 0.05),但60天后未增加(第2组:0.59±0.13%)(方差分析[ANOVA],P < 0.0002)。第4组在采集Tx - 250胰岛后β细胞复制增加(0.94±0.16%,P < 0.05)。高血糖组中最初的移植胰岛β细胞数量(0.21±0.014 mg)逐渐减少(第1组:0.13±0.020 mg;第2组:0.048±0.012 mg;P < 0.05)(ANOVA,P = 0.0001)。Tx - 250后恢复正常血糖水平并未改变Tx - 100移植物中的β细胞数量(第3组:0.076±0.008 mg)。然而,采集Tx - 250胰岛后,β细胞数量逐渐增加(第4组:0.11±0.018 mg;第5组:0.14±0.026 mg,P < 0.05),尽管与最初的移植胰岛β细胞数量相比仍减少(P < 0.05)。总之,暴露于严重慢性高血糖的移植胰岛显示β细胞复制受限且β细胞数量逐渐减少。恢复正常血糖后,移植胰岛β细胞恢复了对葡萄糖的复制反应并部分恢复了最初的移植胰岛β细胞数量,这表明即使在长期高血糖后,正常血糖对胰岛移植仍有有益作用。